Solus and Vapotherm join forces in the UK
We are delighted to inform you that as of 28th of February 2019 Solus Medical Ltd. has been acquired by Vapotherm Inc. and have joined forces in the UK to better serve our customers and their patients.
In the UK Solus Medical and Vapotherm have a long-standing partnership and have jointly served the United Kingdom respiratory market with the Precision Flow® system and our Hi-VNI Technology.
Your local support and contact at Solus will remain the same. We are looking forward to continuing our relationship with you and will keep our high level of support and service.
By joining forces, we see the opportunity to strengthen our offering to the market and bring Hi-VNI Technology to even more patients in the NHS.
Vapotherm (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire in the USA. The company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Globally more than 1.5 million patients have been treated with Vapotherm Hi-VNI® Technology.